Drug intelligence / Profile preview

methylazoxymethanol acetate

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal (experimental), Subcutaneous (experimental)
01

Overview

Methylazoxymethanol acetate (MAM) is a synthetic azoxy compound and neurotoxin that inhibits DNA synthesis and selectively targets rapidly proliferating neuroblasts in the central nervous system. It is primarily used in research to create animal models of neurological and neurodevelopmental disorders, especially schizophrenia and epilepsy, by prenatal administration in rodents, which results in brain structural and behavioral deficits analogous to features of those diseases. MAM acts as a potent alkylating agent, which underlies its genotoxic and neurotoxic properties. It is considered a suspected carcinogen, and is not used as a pharmaceutical.[1][4][5][6][7][9]

Other names
cycasin acetatemamacmamacetatemethylazoxymethyl acetate(methyl-ONN-azoxy)methyl acetateMAM acetate
02

Targets

DNA

Beyond the preview

Go deeper on methylazoxymethanol acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylazoxymethanol acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call